For pharmaceutical companies, bringing a new drug to market can now require up to $2.6 billion and 10-15 years—slowing potentially life-saving drugs from getting to the patients who need them and resulting in abandonment of drug trials when faced with potential failure. Without efficient information access and management, drug companies will find it difficult to accelerate results and lower development costs.
MarkLogic’s Data Hub Service for pharma R&D can help. The hub provides researchers with easy access to the widest possible array of R&D data. And because all of this data can be integrated 10X faster than with custom-developed solutions, the hub makes it possible to quickly and easily find, synthesize, and share information—accelerating and improving R&D processes.